Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,981,354
-
Share change
-
+1,031,627
-
Total reported value
-
$280,753,156
-
Price per share
-
$18.74
-
Number of holders
-
65
-
Value change
-
+$16,983,060
-
Number of buys
-
50
-
Number of sells
-
21
Institutional Holders of RA PHARMACEUTICALS INC - COM (RARX) as of Q2 2017
As of 30 Jun 2017,
RA PHARMACEUTICALS INC - COM (RARX) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,981,354 shares.
The largest 10 holders included
NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, Novo Holdings A/S, RA CAPITAL MANAGEMENT, LLC, VHCP Management II, LLC, BlackRock Inc., Rock Springs Capital Management LP, Tekla Capital Management LLC, ACUTA CAPITAL PARTNERS, LLC, and VANGUARD GROUP INC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.